-
TCM has role in treating respiratory symptoms: Expert
2024-02-02
Traditional Chinese medicine has a distinctive advantage in coping with the wave of respiratory illnesses that has struck China this winter, according to a senior TCM expert.
-
Tegileridine Fumarate Injection Approved for Marketing by China NMPA
2024-01-31
Recently, the Category 1 innovative product Tegileridine Fumarate Injection (trade name: 艾苏特) of Jiangsu Hengrui Pharmaceuticals Co., Ltd. was approved for marketing by China NMPA. It is indicated for moderate to severe pain after abdominal surgery.
-
Innovative TCM Ercha Shangqing Wan approved for marketing
2024-01-24
Recently, the Category 1.1 innovative traditional Chinese medicine (TCM) Ercha Shangqing Wan of Hubei Qijin Pharmaceutical Co Ltd was approved for marketing by China's National Medical Products Administration.
-
China's TCM institutions provide diagnoses, treatment to 1.28 bln people in 2023
2024-01-23
Traditional Chinese medicine (TCM) health care institutions provided diagnoses and treatment to an estimated 1.28 billion people across China in 2023, according to a national TCM meeting that opened on Monday.
-
Gastric Bypass Stent System Approved for Marketing
2024-01-17
Recently, the innovative product "Gastric Bypass Stent System" of Hangzhou Tongee Medical Technology Co., Ltd. was approved by China NMPA.
-
Ganagliflozin Proline Tablets Approved for Marketing by China NMPA
2024-01-19
Recently, the Category 1 innovative product Ganagliflozin Proline Tablets (trade name: 惠优静) of Jilin Huisheng Biopharmaceutical Co,. Ltd. was approved for marketing by China NMPA.
